Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Fluid restriction following open aortic aneurysm surgery
ISRCTN ISRCTN52446152
ClinicalTrials.gov identifier
Public title Fluid restriction following open aortic aneurysm surgery
Scientific title Does peri-operative fluid restriction affect renal function following major abdominal aortic surgery? A single centre randomised controlled trial
Acronym PORAS study
Serial number at source A091805
Study hypothesis Fluid restriction following elective open infra-renal abdominal aortic surgery will affect biomarkers of renal impairment.
Lay summary
Ethics approval Cambridgeshire 3 Research Ethics Committee (REC) approved on the 8th January 2010 (ref: 09/H0306/87)
Study design Single centre randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Elective infra-renal aortic aneurysm surgery
Participants - inclusion criteria Elective patients (aged over 18 years, either sex) undergoing open infra-renal abdominal aortic aneurysm (AAA) repair.
Participants - exclusion criteria 1. Patients undergoing endovascular aortic aneurysm repair
2. Patients undergoing emergency surgery
3. Elective suprarenal AAA repair
4. Severe cardiac failure (New York Heart Association [NYHA] grade IV or myocardial infarction [MI] less than 3 months)
5. Pre-operative serum creatinine greater than 150 mg/dL
6. Pre-operative serum urea greater than 20 mmols/dl
7. Previous history of renal disease
8. Previous renal transplant
9. Patient scheduled to have simultaneous renal procedure at time of surgery
10. Established renal failure requiring renal replacement therapy
11. Previous history of hepatic disease
Anticipated start date 01/02/2010
Anticipated end date 01/04/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 24
Interventions The intervention group will have a fluid restricted regime, of 1.5 L intravenous (IV) fluid per day post-operatively compared to 3 L in the standard regime group. Of course, there is provision for fluid resuscitation in the event that the patient requires this.

The total duration of treatment is 5 days and the follow up is only inpatient.
Primary outcome measure(s) Urinary levels of interleukin-18 (IL-18), neutrophil gelatinase-associate lipocalin (NGAL), retinol binding protein (RBP), albumin/creatinine ratio (ACR), measured at baseline (pre-operative), 6 hours, 12 hours, 24 hours, day 2 ,day 3, day 4, day 5
Secondary outcome measure(s) All measured as inpatient outcomes:
1. All major complications
2. Major adverse cardiac event (myocardial infarction, unstable angina, arrhythmia)
3. Respiratory complications (including need, duration and extent of ventilatory support)
4. Neurological complications (delirium, stroke)
5. Mortality
6. Length of stay
7. Intensive care unit (ITU)/high dependency unit (HDU) stay
8. Wound dehiscence
9. Gastrointestinal outcome measures:
9.1. Time to passage of first flatus
9.2. Time to passage of first faeces
9.3. Nausea scores
9.4. Time to resumption of normal diet
Sources of funding Addenbrookes Charitable Trust (UK) - Vascular Surgery Research Fund
Trial website
Publications
Contact name Dr  Ayesha  Noorani
  Address Cambridge Vascular Unit
Box 201
Addenbrookes Hospital
  City/town Cambridge
  Zip/Postcode CB2 2QQ
  Country United Kingdom
Sponsor Cambridge University Hospitals NHS Foundation Trust (UK)
  Address Research and Development Department
Box 277, Hills Road
  City/town Cambridge
  Zip/Postcode CB2 0QQ
  Country United Kingdom
  Sponsor website: http://www.cuh.org.uk/research/
Date applied 26/01/2010
Last edited 14/07/2010
Date ISRCTN assigned 14/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central